Ipratropium Bromide

CAS number： 22254-24-6

Molecular formula： C20H30BrNO3

molecular weight： 412.36

Chemical structure：

Producers shown on SFDA

(Record date:18/10/2021）

Producer	Documents	GMP Valid till(based on SFDA)
Jewim Pharmaceutical (Shandong) Co., Ltd.	GMP	Valid till January 2022
CR Double-Crane Pharmaceutical Co.,Ltd.	GMP	Valid till August 2021

Producers shown on EP

(Quoted from EP website；record date:18/10/2021）

Substance	Certificate Holder	Certificate Number	Issue Date	Status	End date	Type
Ipratropium bromide	Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE	R1-CEP 1996-005 - Rev 05	08/10/2015	Valid	/	Chemical
Ipratropium bromide	CIPLA LIMITED Mumbai IN	R0-CEP 2015-340 - Rev 00	16/12/2016	Valid	/	Chemical
Ipratropium bromide	AARTI INDUSTRIES LIMITED Mulund (W), Mumbai IN	R1-CEP 2008-150 - Rev 01	14/02/2017	Valid	/	Chemical
Ipratropium bromide	MELODY HEALTHCARE PVT. LTD. Boisar IN	R0-CEP 2017-302 - Rev 01	19/06/2020	Valid	/	Chemical
Ipratropium bromide	Lusochimica S.p.A. Lomagna IT	R1-CEP 2004-220 - Rev 01	26/11/2020	Valid	/	Chemical
Ipratropium bromide	OLON S.P.A. Rodano IT	R1-CEP 1998-083 - Rev 08	28/06/2021	Valid	/	Chemical
Ipratropium bromide	NEULAND LABORATORIES LIMITED Hyderabad IN	R1-CEP 2012-126 - Rev 01	07/09/2021	Valid	/	Chemical

Producer:Jewim Pharmaceutical (Shandong) Co., Ltd. is located in an area of 200 mu, All the dosage forms of the company's listed products have passed the inspection and certification of the China food and drug administration, and the quality system has repeatedly passed the GMP certification of the Australian drug administration (TGA). The products are exported to more than 50 countries such as the United States, Australia and New Zealand.

Staff size:900-999 persons

Registered capital:RMB 100 million

Producer: CR Double-Crane Pharmaceutical Co.,Ltd.was established in 1939.

The company currently has 21 subsidiaries and more than 11000 employees. Its main business includes new drug R & D, preparation production, drug sales, pharmaceutical equipment and API production. It has rich product lines, high-quality product quality, strong channel and terminal coverage and management ability, good brand advantages and international advantages, profound corporate culture and dynamic talent team, economic strength, competitive vitality and sustainable development ability, and ranks in the forefront of domestic pharmaceutical enterprises.

Staff size:11000-11999 persons

Registered capital:RMB 1 billion 43 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978